Figure 4.
Predicted association of dys-regulated LncRNAs to altered mRNA expression in cocaine and Tat treated HPASMCs. (A) Table lists microarray details of selected top lncRNA/mRNA predicted associations. (B) KEGG pathway enrichment for mRNAs associated to lncRNAs based on genomic proximity (<300kbp). (C,D) Quantitative RT-PCR based validation of selected lncRNA/mRNA pairs from vascular disease and cancer co-expression database (C); and from genomic proximity (D) analysis. p-value *<0.05 vs. control (Con), ##<0.01, #<0.05 vs. cocaine(Coc), $$<0.01, $<0.05 vs. Tat.